Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 20, 2026

  1. Minor: Belzutifan (MK-6482) Versus Everolimus · Advanced Renal Cell Carcinoma (MK-6482-005) Study completion pushed from Sep 17, 2026 to Nov 11, 2026 Merck Sharp & Dohme LLCPhase 3 NCT04195750
  2. Minor: IPN10200 · Moderate to Severe Wrinkle-like Lines Between the Eyebrows Primary completion moved earlier from Apr 10, 2028 to May 6, 2027 IpsenPhase 3 NCT07779252
  3. Minor: Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer Final enrollment: 325 participants (planned 400) Seagen, a wholly owned subsidiary of PfizerPhase 3 NCT05253651
  4. Minor: Closure of Left Atrial Appendage · Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy Trial sites expanded: 32 → 35 locations Insel Gruppe AG, University Hospital BernNot applicable NCT05976685
  5. Minor: Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation Trial sites expanded: 6 → 9 locations Fundación EPICNot specified NCT07566624
  6. Minor: Rozanolixizumab · Generalized Myasthenia Gravis Primary and study completion moved earlier from Oct 15, 2027 to Jun 3, 2027 UCB Biopharma SRLPhase 4 NCT07246564
  7. Minor: Data Collection Initiative on Thoracic Malignancies Trial sites expanded: 23 → 29 locations Dutch Society of Physicians for Pulmonology and TuberculosisNot specified NCT06996249
  8. Minor: German Dementia Registry Trial sites expanded: 24 → 29 locations RWTH Aachen UniversityNot specified NCT07433010
  9. Minor: IL-15 Enhanced NK Cell Therapy for Solid Tumors Start date changed from estimate of Oct 8, 2026 to Nov 18, 2026 Genovn Therapeutics (Suzhou) Co., Ltd.Early Phase 1 NCT07621471
  10. Minor: Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting Study completion pushed from Dec 2026 to Mar 2027 SandozNot specified NCT05633771
  11. Minor: Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile Start date changed from estimate of Oct 29, 2026 to Nov 12, 2026 National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 NCT07649096
  12. Minor: Infliximab for Immune Checkpoint Inhibitor Associated AKI Start date changed from estimate of Sep 15, 2026 to Nov 9, 2026 Massachusetts General HospitalPhase 4 NCT07683975
  13. Minor: FOCUS Pre-Post Study Start date moved earlier from Aug 29, 2026 to Jul 27, 2026 University of UtahNot applicable NCT07664514
  14. Minor: Apremilast Pregnancy Exposure Registry Study completion pushed from Jul 2025 to May 2027 University of California, San DiegoNot specified NCT02775500
  15. Minor: Leveraging EA8191 to Assess AI-Augmented EHR Abstraction Study completion pushed from Dec 2026 to Mar 2027 University of PennsylvaniaNot specified NCT06561230
  16. Minor: Pranayamic Breathing and Tongue Exercises on Oral Microbiota in Children Primary completion date changed from estimate of Sep 15, 2026 to Jul 17, 2026 Gulcin OzsenNot applicable NCT07755111
  17. Minor: Psychological Treatment · Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot Trial Start date changed from estimate of Sep 2026 to Nov 18, 2026 Karolinska InstitutetNot applicable NCT07755774
  18. Minor: Knife Movement Rate Training for Endoscopic Submucosal Dissection Interventions modified Fudan UniversityNot applicable NCT07939009
  19. Minor: Individuals With Spinal Cord Injury Study completion pushed from Jul 1, 2026 to Jul 1, 2027 Shirley Ryan AbilityLabNot applicable NCT03644277
  20. Minor: Church-based Intervention to Improve Physical Function Study completion pushed from Sep 1, 2026 to Jun 30, 2027 Rush University Medical CenterNot applicable NCT05345041
  21. Minor: EHR Alerts to Improve GLP-1 Medication and Continuous Glucose Monitor Prescribing in Primary Care Start date changed from estimate of Nov 2026 to Oct 28, 2026 Montefiore Medical CenterNot applicable NCT07948928
  22. Minor: Acupressure on Blood Glucose And Anxiety in Elderly With Diabetes Study completion pushed from Oct 27, 2026 to Dec 27, 2026 Abant Izzet Baysal UniversityNot applicable NCT07356024
  23. Minor: Sexual Quality of Life · Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the Menopause Primary and study completion moved earlier from Dec 2027 to Jun 2027 Institut du Cancer de Montpellier - Val d'AurelleNot applicable NCT06347926
  24. Minor: Cemiplimab With Chemotherapy and Immunotherapy · Head and Neck Cancer Trial arms changed: 2 → 3 Memorial Sloan Kettering Cancer CenterPhase 1 NCT04722523
  25. Stopped: Selinexor (KPT-330) · Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Trial terminated Karyopharm Therapeutics IncPhase 2 NCT02227251